Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia
Zachary R. Hunter(Harvard University), Steven P. Treon(Dana-Farber Cancer Institute), Christopher J. Patterson(Dana-Farber Cancer Institute), Kenneth C. Anderson(Dana-Farber Cancer Institute), Nicholas Tsakmaklis(Shaanxi Research Association for Women and Family), Joshua Gustine(Boston University), Robert Manning(Harvard University), Jiaji G. Chen(Shaanxi Research Association for Women and Family), Toni Dubeau(Shaanxi Research Association for Women and Family), Guang Yang(Blueprint Medicines (United States)), Philip Brodsky(Dana-Farber Cancer Institute), Jie Chen(Dana-Farber Cancer Institute), Xia Liu(Dana-Farber Cancer Institute), Nikhil M. Munshi(Harvard University), Jorge J. Castillo(Dana-Farber Cancer Institute), Lian Xu(Huazhong Agricultural University), Josephine M. I. Vos(Sanquin)
Cited by 95
Related Papers
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k